Investigational drug · Phase 2
ASK0912
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP).
Phase 2Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "ASK0912"
First trial start
2026
Mar 25, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "ASK0912", any sponsor or status.
Conditions studied
As listed on its trial records.
- Ventilator-associated Bacterial Pneumonia (VABP)
- Hospital-acquired Bacterial Pneumonia (HABP)
Approved drugs for the same conditions: Pneumonia · Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "ASK0912" as an intervention, largest first.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.Industry
NCT07759934 · 60 participants (planned) · Start Mar 25, 2026 · Primary completion Oct 20, 2027
Drug: ASK0912 for Injection; ASK0912 for Injection and 1 more · For: Ventilator-associated Bacterial Pneumonia (VABP); Hospital-acquired Bacterial Pneumonia (HABP)
Sites: Nanjing, China
Newest research
PubMed records naming it or its code names, newest first.
- Protective effect of the novel cyclic peptide ASK0912 on mice with sepsis induced by Acinetobacter baumannii.
Xie C, Wang P, Wu H, et al. · Biomed Pharmacother 2023
Also in development for Ventilator-associated Bacterial Pneumonia (VABP)
- PralurbactamPhase 33 trials
Qilu Pharmaceutical Co., Ltd. · Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI)
- HRS-8427Phase 32 trials
Jiangsu HengRui Medicine Co., Ltd. · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP), Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)
- YK-1169Phase 31 trial
Nanjing Yoko Biomedical Co., Ltd. · Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.